Multiplexed Serum Biomarkers for the Detection of Lung Cancer.
Ontology highlight
ABSTRACT: Currently, there is no available biomarker for lung cancer diagnosis. Here we recruited 844 lung cancer patients and 620 healthy participants from six hospitals. A total of four serum proteins was identified and subsequently assessed in the training and validation cohorts. The concentrations of four serum proteins were found to be significantly higher in lung cancer patients compared with healthy participants. The area under the curve (AUC) for the 4-biomarker were 0.86 in the training cohort, and 0.87 in the validation cohort. The classification improved to a corrected AUC of 0.90 and 0.89 respectively following addition of sex, age and smoking status. Similar results were observed for early-stage lung cancer. Remarkably, in a blinded test with a suspicious pulmonary nodule, the adjusted
SUBMITTER: Ma S
PROVIDER: S-EPMC5049985 | biostudies-literature | 2016 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA